Retatrutide: Inside the Triple Agonist Redefining Metabolic Research
Semaglutide changed the conversation. Tirzepatide pushed it further. Now researchers are turning their attention to retatrutide — a compound that targets not two but three hormone receptors simultaneously, and is emerging as one of the most studied peptides in contemporary…